Insider Trading January 23, 2026

Consumers Bancorp Director Increases Stake with $5,472 Stock Acquisition

David R. Bickerton adds to holdings as share prices near annual peak

By Avery Klein CBKM
Consumers Bancorp Director Increases Stake with $5,472 Stock Acquisition
CBKM

David R. Bickerton, a board member of Consumers Bancorp Inc, recently enhanced his investment in the company by purchasing 200 shares valued at $5,472. These acquisitions occurred in two transactions on January 23, 2026, at prices slightly above $27 per share. Consumers Bancorp's stock is trending near its highest level in the last year, reflecting notable appreciation for the small-cap bank.

Key Points

  • David R. Bickerton, director at Consumers Bancorp, purchased 200 shares valued at $5,472 on January 23, 2026.
  • Shares were bought at prices between $27.33 and $27.3988, as the stock trades near its 52-week high of $27.15.
  • Consumers Bancorp presents a P/E ratio of 8.8 and a 3.12% dividend yield with a 27-year history of dividend payments.

David R. Bickerton, serving as a director at Consumers Bancorp Inc (NASDAQ: CBKM), has expanded his equity stake by acquiring 200 additional shares of the company's common stock, totaling an investment of $5,472 according to a recent Securities and Exchange Commission Form 4 disclosure. These purchases took place in two distinct transactions on January 23, 2026, with shares procured at prices ranging from $27.33 to $27.3988 each.

In one transaction, Bickerton directly bought 100 shares, while the second involved the acquisition of 100 shares through indirect ownership via his spouse. Post-acquisition, his direct ownership in Consumers Bancorp rises to 4,306 shares. This stock transaction occurs while the bank's shares are trading near their 52-week high of $27.15 and the company’s market capitalization stands at approximately $84.59 million.

Consumers Bancorp is characterized by an appealing price-to-earnings ratio of 8.8 and offers investors a dividend yield of 3.12%, a testament to its consistent payout record extending over 27 years. Analytical insights from InvestingPro indicate that the stock shows a slight undervaluation, accompanied by more than ten additional investment tips accessible to subscribers.

This incremental purchase by a company insider may provide investors with a perspective on internal confidence, especially as the bank demonstrates stability through dividend consistency and valuation metrics. Nevertheless, the small-cap nature of Consumers Bancorp and the intrinsic market volatility in the financial sector should guide consideration of associated investment risks.

Risks

  • The small-cap status of Consumers Bancorp may lead to higher volatility in stock price.
  • Stock trading near 52-week high suggests limited upside in short term if valuation ceases to attract buyers.
  • Banking sector dynamics and market conditions could impact dividend sustainability and stock valuation.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026